Concepedia

Rakesh K. Srivastava

RK

Statistics

Publications

101

Citations

8.3K

H-Index

53

Active since

1979

Affiliations

University of Maryland, Baltimore(Current)

Kansas City VA Medical Center

The University of Texas Health Science Center at Tyler

University of Kansas Medical Center

National Institutes of Health

Rakesh K. Srivastava is an author at University of Maryland, Baltimore specializing in oncology, molecular oncology, and life sciences.

Publications per year

1979–2022

101

Publications

101

Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways

Ayoub Suliman, Arh Lam, Rakesh Datta et al. · Oncogene · 2001 · 422 citations

Life Sciences, Cell Biology, Molecular Biology +14

Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer

Sanjit K. Roy, Rakesh K. Srivastava, Sharmila Shankar · Journal of Molecular Signaling · 2010 · 376 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis

Rakesh K. Srivastava, Qing-Sheng Mi, J. Marie Hardwick et al. · Proceedings of the National Academy of Sciences · 1999 · 336 citations

Life Sciences, Cell Biology, Pharmacology +17

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

Xufeng Chen, Hitesh Thakkar, Frazier Tyan et al. · Oncogene · 2001 · 298 citations

Medicine, Molecular Biology, Oncology +14

Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.

Thiyam Ramsing Singh, Sharmila Shankar, Xufen Chen et al. · PubMed · 2003 · 247 citations

Life Sciences, Oncology, Pharmacology +17

1–5 of 101